细胞和线粒体通路有助于SGLT2抑制剂介导的组织保护:实验和临床数据
Raúl Lelio Sanz1, Sebastián García Menéndez1,2, Felipe Inserra3
1Departamento de Patologie et Pharmacologie, Instituto de Medicina y Biologia Experimental de Cuyo, Consejo Nacional de Investigación Cientifica y Tecnológica (IMBECU- CONICET), Mendoza 5500, Argentina.
Current pharmaceutical design
|March 29, 2024
概括
-葡萄糖共传输体2抑制剂 (SGLT2i) 通过增强线粒体功能和减少代谢障碍中的氧化应激和炎症来改善心血管健康. 这些药物为保护心脏组织和预防不良事件提供了一个有希望的治疗策略.
科学领域:
- 心血管医学 心血管医学
- 代谢障碍 代谢障碍 代谢障碍
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体功能受损导致代谢综合征和糖尿病中的心血管疾病.
- ангиотензин II 和低 sirtuin 活性加剧氧化应激,炎症和心脏重塑.
- 减少线粒体能量生产是代谢障碍的标志.
研究的目的:
- 研究SGLT2抑制剂 (SGLT2i) 在调节线粒体功能和心血管疾病相关途径中的作用.
- 阐明SGLT2i在代谢障碍的背景下发挥心脏保护作用的机制.
主要方法:
- 对SGLT2抑制剂的随机临床试验和机制学研究的综述.
- 对SGLT2i对线粒体效率,氧化应激,炎症和自/线粒体自的影响的分析.
- 探索sirtuins,AMPK和缺氧诱导因素之间的相互作用.
主要成果:
- SGLT2 抑制剂显著改善心脏功能,减少心血管和事件.
- SGLT2i提高线粒体效率,降低氧化应激,减少炎症.
- SGLT2i促进了自和髓,清除了细胞碎片并保护了心脏组织.
结论:
- SGLT2 抑制剂对线粒体功能具有深远的有益作用,为代谢障碍中的心血管保护提供了强有力的治疗策略.
- 通过提高线粒体效率和减少炎症,SGLT2i充当"细胞超分子".
- 对SGLT2i线粒体作用的进一步研究可能会为心血管健康开辟新的治疗途径.
相关概念视频
Secondary Active Transport
7.0K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.0K
Glucose Absorption Into the Small Intestine
31.6K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.6K
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
196
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
196
Dipeptidyl Peptidase 4 Inhibitors
184
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
184
Transcellular Transport of Solutes
3.6K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.6K


